Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.2504 (-5.86%) ($6.2488 - $6.5874) on Thu. Sep. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 46 | Latest Price | $6.2504(-5.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -3.3% a day on average for past five trading days. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UNG(7%) IGOV(6%) ICLN(5%) FIVG(4%) | Factors Impacting EYES price | EYES will decline at least -1.645% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) LQD(-6%) VUG(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 0 () | Intraday Trend | -4.7% | | | |
|
Resistance Level | $6.77 | 5 Day Moving Average | $6.8(-8.08%) | 10 Day Moving Average | $6.98(-10.45%) | 20 Day Moving Average | $6.77(-7.68%) | To recent high | -18.6% | To recent low | 7% | Market Cap | $1.996b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |